Medicare Advantage and Cancer: What Beneficiaries Must Know

For the roughly 4 million Medicare beneficiaries living with a cancer diagnosis — and the many more who will receive one — the choice between Medicare Advantage and Original Medicare is not just a financial decision. It can directly shape which oncologists you can see, how quickly you can start treatment, and how much you'll owe out of pocket during some of the most medically intensive months of your life. The concerns are real, documented, and worth understanding in detail before you make a plan decision during the Annual Enrollment Period, which runs October 15 through December 7 each year.

Medicare Advantage plans, also called Medicare Part C, are offered by private insurers and must cover everything Original Medicare covers — but they do so through managed care structures that include provider networks, referral requirements, and prior authorization rules. For a healthy beneficiary managing routine care, these structures may cause little friction. For someone undergoing chemotherapy, radiation, immunotherapy, or surgical oncology, those same structures can become significant obstacles. Prior authorization — the requirement that your insurer approve a treatment before it's delivered — is used far more extensively in Medicare Advantage than in Original Medicare. A 2022 report from the HHS Office of Inspector General found that Medicare Advantage plans denied 13% of prior authorization requests for services that met Medicare coverage rules, meaning care that would have been covered under Original Medicare was initially refused. For cancer patients, delays of even a few weeks in starting chemotherapy or targeted therapy can have clinical consequences.

The network issue compounds the prior authorization problem. Top-ranked cancer centers — places like MD Anderson, Memorial Sloan Kettering, Mayo Clinic's oncology programs, and major NCI-designated cancer centers — frequently do not participate in Medicare Advantage networks, or participate in only a limited number of plans. Original Medicare, by contrast, allows you to see any provider in the country who accepts Medicare assignment, with no referral required. If you're diagnosed with a rare or aggressive cancer and want a second opinion at a specialized center, Original Medicare gives you that freedom automatically. Under Medicare Advantage, going out of network can mean paying the full cost of that consultation yourself, or finding it simply isn't covered at all under an HMO-structured plan.

Cost-sharing under Medicare Advantage deserves a hard look for anyone with a serious diagnosis. In 2025, the maximum out-of-pocket limit for Medicare Advantage plans is $9,350 for in-network services and can be higher — sometimes $14,000 or more — when out-of-network costs are included under PPO plans. Cancer treatment can push a beneficiary to that cap quickly. A single inpatient hospitalization for a surgical procedure, followed by chemotherapy infusions, radiation sessions, and specialist visits, can generate cost-sharing obligations in the thousands within the first month of treatment. Under Original Medicare without a supplement, you'd face a $1,676 inpatient deductible per benefit period in 2025, plus 20% coinsurance for outpatient services with no cap — which is its own serious exposure. But with a Medigap plan (specifically Plan G, the most comprehensive option available to new enrollees), that 20% coinsurance and most other cost-sharing is covered, leaving you with far more predictable expenses.

This is where hospital indemnity insurance enters the picture as a meaningful financial tool — particularly for beneficiaries who are already enrolled in Medicare Advantage and either cannot or choose not to switch. Hospital indemnity plans pay a fixed daily cash benefit when you're admitted to a hospital, typically ranging from $100 to $500 per day depending on the policy, and some plans include additional benefits for ICU stays, surgical procedures, or cancer-specific diagnoses. These benefits are paid directly to you, not to the provider, which means you can use them to cover Medicare Advantage copays, transportation to treatment centers, home care costs, or lost household income if a spouse or caregiver reduces work hours. For a cancer patient spending 10 days in the hospital for a major surgery, a $300-per-day hospital indemnity benefit generates $3,000 in cash — money that can meaningfully offset the $1,500 or more in daily cost-sharing that some Medicare Advantage plans impose for inpatient stays beyond the first few days.

It's worth being honest about what hospital indemnity insurance is not. It is not a substitute for comprehensive coverage. It won't cover your chemotherapy copays, your specialist visit fees, or your prescription drug costs under a Medicare Advantage plan's formulary. If you have a serious cancer diagnosis and are enrolled in Medicare Advantage, the more powerful financial move — if you're eligible — is to switch to Original Medicare paired with a Medigap plan during a qualifying window. The Annual Enrollment Period (October 15–December 7) lets you drop Medicare Advantage and return to Original Medicare, effective January 1. However, returning to Original Medicare does not automatically guarantee you Medigap access. In most states, Medigap insurers can use medical underwriting outside of guaranteed issue windows, meaning a cancer diagnosis could result in a higher premium or denial. If you're in California, New York, Oregon, Illinois, or one of the other birthday rule states — including Idaho, Kentucky, Louisiana, Maine, Maryland, Missouri, Nevada, New Jersey, or Oklahoma — you may have a 30-day window around your birthday each year to switch Medigap plans without medical underwriting, which can be a critical opening for beneficiaries whose health has changed.

For beneficiaries who are newly enrolling in Medicare at 65 and have a cancer history or are currently in treatment, the guaranteed issue window at initial enrollment is your most protected moment. During the six-month Medigap Open Enrollment Period that begins when you're both 65 and enrolled in Medicare Part B, no insurer can deny you a Medigap policy or charge you more based on your health status. Choosing Original Medicare plus a Medigap Plan G during this window — rather than defaulting to a Medicare Advantage plan because of its lower premium — may be one of the most financially protective decisions a cancer patient or survivor can make. Medigap Plan G premiums vary by age, location, and insurer, but typically range from $100 to $200 per month for a 65-year-old, a cost that can be far less than the accumulated cost-sharing under Medicare Advantage during active cancer treatment.

If you're currently in a Medicare Advantage plan and facing a new cancer diagnosis mid-year, check whether you qualify for a Special Enrollment Period. Certain qualifying life events — including moving out of your plan's service area or losing employer coverage — can trigger an SEP that lets you switch plans outside the standard enrollment windows. A diagnosis alone does not trigger an SEP, but it's worth calling 1-800-MEDICARE or your State Health Insurance Assistance Program (SHIP) counselor to review your specific situation. SHIP counselors provide free, unbiased help and can walk you through your options without trying to sell you anything. You can find your state's SHIP contact through the Medicare.gov website or by calling the main Medicare helpline.

The bottom line for cancer patients and those at elevated risk is this: Medicare Advantage plans are not inherently bad, and for many healthy beneficiaries they offer real value through low premiums, dental and vision benefits, and care coordination. But the structural features that make them efficient for routine care — networks, prior authorization, tiered cost-sharing — can become serious liabilities when you need intensive, specialized, or ongoing oncology care. Hospital indemnity insurance can soften the financial blow for those already in Medicare Advantage, but it works best as a complement to thoughtful plan selection, not a replacement for it. Review your coverage every Annual Enrollment Period with your specific health needs in mind, and don't let a low monthly premium be the only number you consider.